ArticleThe Lancet. Oncology2017
Adjuvant ipilimumab for stage III melanoma: the patient voice.
Michael Brundage et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ArticleThe Lancet. Oncology2017
Michael Brundage et al.PubMed ↗Publisher ↗
No numbers read from the abstract.